Postoperative Delirium in Hip Fracture Patients
Risk factors for postoperative delirium in hip fracture patients...
Brief Summary
Official Title: “Postoperative Delirium in Hip Fracture Patients”
Risk factors for postoperative delirium in hip fracture patients.
- Study Type: Observational
- Study Design: Observational Model: Cohort, Time Perspective: Prospective
Outcome Measures for this Clinical Trial
Primary Measures
- Delirium/ no-delirium
- Time Frame: 5 days postoperative
- Time Frame: 5 days postoperative
Secondary Measures
- Severity of delirium, length of delirium, complications, comorbidity, one-year mortality.
- Time Frame: 5 days postoperative, one year
- Time Frame: 5 days postoperative, one year
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- hip fracture
- age 65 or older
Exclusion Criteria:
- critical ill/ dying
- aphasia
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 65 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Ullevaal University Hospital Other
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00564434
Study ID Number: 1.2005.812
ClinicalTrials.gov Identifier: NCT00564434
Health Authority: Norway: The National Committees for Research Ethics in Norway
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00564434
